GlaxoSmithKline reports success for Phase I trial of Ebola vaccine
In association with the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Okairos, GlaxoSmithKline has developed an Ebola vaccine candidate that has proved ...